Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

FDA Approves Rexulti for Treating Agitation Due to Alzheimer's - MyChesCo

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA

REXULTI® (brexpiprazole) Agitation associated with dementia due to Alzheimer's disease

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference

Otsuka and Lundbeck Receive the US FDA's Approval for Rexulti (brexpiprazole) sNDA to Treat Agitation Associated with Dementia Due to Alzheimer's Disease